内蒙古巴彦淖尔地区临床型奶牛乳腺炎病原菌的鉴定

不同地区奶牛乳腺炎的主要致病菌不同,其发病率也存在很大的差异。为了进一步明确内蒙古巴彦淖尔地区奶牛乳腺炎的发病情况,以巴彦淖尔地区4家奶牛场临床型乳腺炎患牛为实验对象,采集80份乳样进行了病原菌的分离培养及生化鉴定,结果分离到51个菌株,其中有葡萄球菌31株,链球菌6株,肠杆菌14株。该试验明确了该地区奶牛乳腺炎的主要致病菌,为该地区奶牛乳腺炎的有效防治及临床上合理地筛选敏感药物提供了有if,4的依据。     

盐酸克林霉素对奶牛急性乳房炎病的疗效试验

对奶牛急性乳腺炎病原菌进行了分离和鉴定,鉴定出致病菌是金黄色葡萄球菌和B群无乳链球菌.用平皿二倍稀释法测定了克林霉素等12种药物对临床分离的16株金黄色葡萄球菌和10株无乳链球菌的MIC.结果显示,金黄色葡萄球菌和无乳链球菌对克林霉素敏感.临床疗效试验结果表明,克林霉素组的治愈率与感染对照组比较差异极显著(P＜0.01),克林霉素组治愈率、有效率与其它对照组比较差异显著(P＜0.05),表明克林霉素对奶牛乳腺炎病的治疗有很好的疗效.     

主要致病菌引发的奶牛乳房炎的防治

奶牛乳腺炎最主要原因是病原微生物感染,是影响奶业发展的最为严重的疾病之一,临床感染以金黄色葡萄球菌的带菌率最高,其次是大肠杆菌、无乳链球菌、停乳链球菌等。本文就奶牛乳腺炎的主要致病菌、临床症状,诊断方法及其综合防治等方面对其进行综述。     

奶牛乳腺炎病原菌的分离及其药敏试验

在临床调查的基础上,采用普通琼脂培养分离临床型乳腺炎奶牛的病原菌,并用平板纸片法进行药物敏感试验,以确定农场奶牛临床型乳腺炎的致病菌种类及致病菌对不同抗生素的敏感性.结果发现,患临床型乳腺炎奶牛的主要致病菌是葡萄球菌和链球菌,有部分大肠杆菌;泰诺、氨苄青霉素钠、先锋9号和盐酸环丙沙星的抑菌效果较好.结合临床治疗效果观察发现,盐酸环丙沙星对乳腺炎的治疗效果最佳.     

奶牛乳腺炎主要致病菌的分离与鉴定

对山东省济南、泰安和临沂等地区5个奶牛场的160份乳样进行了临床型乳腺炎和隐性乳腺炎的判定检测,并进行了主要致病菌的分离鉴定.结果表明,160份乳样中有127份呈乳腺炎阳性,其中临床型乳腺炎占36.22%,隐性乳腺炎占63.78%;从这些乳样中分离到了主要致病菌金黄色葡萄球菌、大肠杆菌和无乳链球菌,金黄色葡萄球菌依据溶血型的不同主要有α溶血、β溶血、α β溶血和不溶血四种;大肠杆菌依据O抗原诊断血清得出主要有O2、O21、O76和O88这四种型;无乳链球菌依据溶血型主要为β溶血型.     

奶牛乳腺炎病原菌的分离鉴定及中药透皮剂治疗

对佳木斯市8所规模型奶牛场做了乳腺炎发病情况调查,随机采集了88份临床型乳腺炎乳样和176份隐性乳腺炎乳样做了细菌学检查,并对分离得到的病原菌进行鉴定,同时采用中草药透皮剂治疗发病奶牛.试验结果表明,引起奶牛乳腺炎主要病原菌包括金黄色葡萄球菌、表皮葡萄球菌、无乳链球菌、乳房链球菌、化脓链球菌、大肠杆菌、克雷伯氏菌、绿脓杆菌、沙门氏菌;中药透皮剂治疗奶牛乳腺炎实验表明治疗效果良好.     

包头地区临床型奶牛乳腺炎病原菌的分离与鉴定

临床型奶牛乳腺炎主要是由多种非特定病原微生物引发的奶牛乳房及乳汁表现出明显临床症状的一种乳腺疾病。从包头地区5个奶牛场33头奶牛的77份乳样中分离得到98株病原菌,主要病原经生化试验鉴定为金黄色葡萄球菌、表皮葡萄球菌、腐生葡萄球菌、无乳链球菌、乳房链球菌、乳链球菌、牛链球菌、粪链球菌、棒状杆菌属、酵母菌和大肠埃希菌、克雷伯菌属、变形杆菌属、志贺菌属、肠杆菌属、沙门菌属。研究结果可为包头地区临床型奶牛乳腺炎的防治工作提供参考。     

奶牛乳头专用消毒剂——激活碘粉

奶牛乳腺炎是世界奶牛养殖业中发病率最高、流行最快、造成损失最大的疾病之一，引起奶牛乳腺炎的原因很复杂，但主要是病原菌的感染，能引起乳房炎的病原微生物有100多种，但金黄色葡萄球菌、无乳链球菌、停乳链球菌、乳房链球菌和大肠杆菌是最主要的致病菌。     

奶牛临床型乳腺炎致病菌分离鉴定及2种常见用药方案的疗效研究

为了研究奶牛乳腺炎致病菌种类,同时比较青霉素、链霉素合并使用与沃瑞特单独使用在奶牛临床型乳腺炎的治疗中的疗效差异,以100头患有临床型乳腺炎的奶牛为研究对象,对从乳样中分离到的细菌进行鉴定;在同一饲养管理条件下将上述患牛分为对照组（4头）、沃瑞特组（50头）、青链霉素组（46头）进行疗效对比研究。结果表明,致病菌葡萄球菌的分离率为37.0%、大肠杆菌为30.1%、克雷伯菌为 18.3%、链球菌为2.4%,其他菌为12.2%,占比例最高的是葡萄球菌;2种用药方案均收到良好的治疗效果,青链霉素组治愈率为78.26%,沃瑞特治愈率为66.00%,青链霉素组治愈率显著高于沃瑞特组。     

宁夏部分地区奶牛乳腺炎病原菌的分离鉴定

从宁夏9个县(区)的16个规模化牛场采集327份患乳腺炎奶牛乳样,通过分离培养和生化试验,检出含细菌乳样226份,乳样细菌检出率69.11%(226/327);鉴定出奶牛乳腺炎病原菌5大类9种260株,确认宁夏部分地区奶牛乳腺炎主要病原菌为凝固酶阴性葡萄球菌、停乳链球菌、金黄色葡萄球菌、大肠埃希菌和酵母菌。乳腺炎的发生以单一病原感染为主,占84.96%(192/226);混合感染较少,占15.04%(34/226)。     

Incidence and types of clinical mastitis in dairy herds with high and low somatic cell counts

Eighteen dairy herds were studied, 12 with a 12-month Dairy Herd Improvement Association herd mean somatic cell count (SCC) less than or equal to 150,000 cells/ml (low SCC) and 6 with a 12-month mean SCC greater than 700,000 cells/ml (high SCC). At the outset of the study, quarter samples for bacteriologic culture were collected (in duplicate) from all quarters of all lactating cows (whole herd culture). Subsequently, quarter milk samples for culture from all cows with clinical mastitis were collected for a period of 6 months. In the herds with low SCC, results of whole herd culture revealed low prevalence of intramammary infection attributable to all major pathogens (less than 4% of all quarters). Prevalence of infection with Streptococcus agalactiae (22.2% of all quarters) and Staphylococcus aureus (6.6% of all quarters) was significantly (P less than 0.05) higher in the herds with high SCC. Mean incidence of clinical mastitis in the herds with low SCC was 4.23 infections/100 cows/month (range, 0.42 to 10.25 infections). In the herds with high SCC, mean incidence was 2.91 infections/100 cows/month (range, 1.33 to 3.92 infections). In the herds with low SCC, infection type, as mean percentage of total clinically infected quarters sampled for culture/herd, was 0.0%, 2.2%, 12.3%, 43.5%, and 28.6% for Str agalactiae, S aureus, streptococci other than Str agalactiae, coliforms, and organisms not isolated, respectively. Respective percentages for the herds with high SCC were 41.5%, 18.3%, 12.6%, 8.0%, and 8.8%. During the study period (from April through January), incidence of clinical mastitis and clinical mastitis caused by coliform bacteria were highest in July and August for herds with low SCC.(ABSTRACT TRUNCATED AT 250 WORDS)     

甘肃省某奶牛场肠杆菌性乳房炎主要病原菌的分离鉴定与耐药性分析

为查明甘肃省某奶牛场发生临床型奶牛乳房炎的主要病原菌并选择治疗用敏感药物,随机无菌采集了6份临床型病牛乳样和1份大罐乳样,采用划线分离、菌落形态观察、革兰染色镜检、生化鉴定及16S rDNA序列分析等方法进行细菌分离鉴定,同时采用K-B法测定主要分离菌株对抗菌药物的敏感性。结果表明,从临床型乳房炎乳样中分离鉴定出大肠埃希菌、芽胞杆菌、凝固酶阴性葡萄球菌(腐生葡萄球菌)3种细菌,其中大肠埃希菌的分离率最高,为66.67%;从大罐奶样中也分离出大肠埃希菌。药敏试验结果表明,大肠埃希菌对氨苄青霉素、阿莫西林、头孢噻吩、杆菌肽、红霉素均存在不同程度的耐药,耐药率为29%~100%;对诺氟沙星、恩诺沙星、氟苯尼考、头孢哌酮等药物敏感。说明此次牛场临床型乳房炎的主要病原菌是大肠埃希菌、葡萄球菌和芽胞杆菌,而且分离的大肠埃希菌具有多重耐药性。根据检测分析结果,给奶牛场提出针对性的防控措施,临床型乳房炎的发病率下降,病情得以控制。     

Intramammary infections and risk factors for clinical mastitis in herds with low somatic cell counts in bulk milk

Ten herds with low somatic cell counts in bulk milk had an incidence of clinical mastitis of only 2.2 per 100 cows whereas 10 other herds with similarly low cell counts had an incidence of 53.6 per 100 cows. The major pathogens in the herds with a high incidence were Escherichia coli, Streptococcus uberis, Staphylococcus aureus and the coagulase-negative staphylococci. The percentage of uninfected quarters in the herds with a high incidence of clinical mastitis was 21.4 per cent compared with 12.2 per cent in the herds with a low incidence of clinical mastitis. The prevalence of coagulase-negative staphylococci, Corynebacterium bovis and Micrococcus species was higher in the herds with a low incidence of clinical mastitis. There was a significant linear relationship between the percentage of uninfected quarters and the incidence of clinical mastitis in the herds with a high incidence of clinical mastitis. In herds with a low incidence of clinical mastitis significantly less teat disinfection after milking was practised. The results suggest that infections with minor pathogens tend to protect cows against mastitis, and that teat disinfection after milking may increase the percentage of uninfected quarters and lead to an increased risk of clinical mastitis in herds with low somatic cell counts in bulk milk.     

Prevalence of coagulase-negative staphylococci in bovine mastitis in Zimbabwe

This study was carried out to determine the prevalence of coagulase-negative staphylococci in clinical and subclinical mastitis in commercial and small-scale farms in Zimbabwe. Thirty five quarter milk samples from clinical mastitis cases and 371 quarter milk samples from cows with subclinical mastitis were cultured for bacterial pathogens. The most frequent pathogens isolated in clinical mastitis were the enteric bacteria (31.4%), followed by coagulase negative staphylococci (22.9%) and then Staphylococcus aureus (17.1%), whereas in subclinical mastitis S. aureus (34.2%) and coagulase-negative staphylococci were (33.2%) the most common. Bacillus species were only isolated in milk samples from subclinical mastitis. Coagulase-negative staphylococci were observed in mixed infections with other bacteria in only 2.2 of the 406 milk samples from clinical and subclinical mastitis where they were isolated together with Bacillus species in 6 of the 9 mixed infection cases. About 95% of the milk samples from which 131 coagulase-negative staphylococci were isolated had correspondingly high somatic cell counts. The coagulase-negative staphylococci isolated most frequently were S. chromogenes (7.9%), S. epidermidis (7.4%) and S. hominis (5.9%). They were all associated with high somatic cell counts. All the coagulase-negative staphylococci isolates were susceptible to cloxacillin and erythromycin, and more than 90% of the isolates were susceptible to neomycin, penicillin and streptomycin. The highest resistance was to tetracycline (17.6%), followed by lincomycin (13.7%). About 8% of the isolates were resistant to both penicillin and streptomycin.     

奶牛乳腺炎的细菌学研究

在对山东7个地区14个奶牛场临床型和隐性乳腺炎调查的基础上采集234头临床乳腺炎病牛乳样、241个隐性乳腺炎乳样并分别做了细菌学检查,结果表明:泌乳期临床型乳腺炎病原菌以凝固酶阴性葡萄球菌、金黄色葡萄球菌、链球菌、酵母菌和棒状杆菌为主;干奶期临床型乳腺炎病原菌以大肠杆菌、链球菌、金黄色葡萄球菌、凝固酶阴性葡萄球菌和酵母菌为主;隐性乳腺炎病原菌以凝固酶阴性葡萄球菌、金黄色葡萄球菌链球菌、酵母菌、假单胞菌和棒状杆菌为主;厌氧菌在隐性乳腺炎、干奶期乳腺炎和干奶期乳腺炎乳样的捡出率分别为 5．82％,4．17%,10．16％;隐性乳腺炎、干奶期乳腺炎细菌的共感染率较高,与泌乳期乳腺炎病原菌的差异极显著(P<0．01),隐性乳腺炎与干奶期乳腺炎病原菌共感染率差异不显著(P >0．05)。     

Acute phase proteins in milk in naturally acquired bovine mastitis caused by different pathogens

The concentrations of haptoglobin (Hp) and serum amyloid A (SAA) and the activity of N-acetyl-β-D-glucosaminidase (NAGase) in milk from 234 cows with spontaneous mastitis caused by different pathogens were measured to assess whether they corresponded with the clinical signs of mastitis and whether there were any differences between pathogens. Ninety-eight of the cows had clinical mastitis and 136 had subclinical mastitis. There were statistically significant positive correlations between the concentrations of SAA and Hp and the activity of NAGase. Significant differences in the concentrations of acute phase proteins and NAGase activity were found in milk from cows with mastitis caused by different pathogens. The highest concentrations of Hp and NAGase were found in cases of mastitis caused by Escherichia coli and Arcanobacterium pyogenes, and the lowest concentrations were from cases of mastitis caused by coagulase-negative staphylococci. Very low SAA concentrations were found in milk from the cases caused by A pyogenes, in contrast to cases caused by other major mastitis pathogens. The median concentration of SAA was over 10 times higher in cases of mastitis caused by E coli than in mastitis caused by other pathogens. There were significant differences in the mean Hp concentration and NAGase activity between clinical and subclinical mastitis. In approximately one-third of the samples, the Hp concentration was below the detection limit, potentially compromising the use of Hp as a mastitis marker.     

凉州区奶牛乳房炎主要病原分离鉴定及药敏试验

乳房炎是奶牛最常见的疾病,随着奶牛产业的蓬勃发展,乳房炎已经成为制约该产业的瓶颈之一。从甘肃省武威市凉州区5个奶牛养殖场采集了1 000头荷斯坦奶牛共计3 991份奶样,对临床型和非临床型(隐性)乳房炎分别通过临床症状和兰州隐性乳房炎诊断液(LMT)进行诊断。结果显示:该地区奶牛临床型乳房炎发病率18.20%,亚临床型乳房炎发病率36.50%,总阳性率54.70%,总阳性乳区率54.72%。从阳性奶样中分离纯化得到的主要病原菌为链球菌属、金黄色葡萄球菌和大肠杆菌,且在不同类型乳房炎中的分布情况不同,临床型中链球菌属最多(54.37%),亚临床型中金黄色葡萄球菌最多(48.56%)。对主要病原菌进行药敏试验,结果表明治疗凉州区奶牛乳房炎的最佳药物应为喹诺酮类和庆大霉素类。     

Clinical mastitis in dairy cattle in Ontario: frequency of occurrence and bacteriological isolates.

The objective of this study was to describe the frequency of occurrence of clinical mastitis in dairy herds in Ontario. The study group consisted of 65 dairy farms involved in a 2-year observational study, which included recording all clinical mastitis cases and milk sampling of quarters with clinical mastitis. Lactational incidence risks of 9.8% for abnormal milk only, 8.2% for abnormal milk with a hard or swollen udder, and 4.4% for abnormal milk plus systemic signs of illness related to mastitis were calculated for 2840 cows and heifers. Overall, 19.8% of cows experienced one or more cases of clinical mastitis during location. Teat injuries occurred in 2.1% of lactations. Standard bacteriology was performed on pretreatment milk samples from 834 cows with clinical mastitis. The bacteria isolated were Staphylococcus aureus (6.7%), Streptococcus agalactiae (0.7%), other Streptococcus spp. (14.1%), coliforms (17.2%), gram-positive bacilli (5.5%), Corynebacterium bovis (1.7%), and other Staphylococcus spp. (28.7%). There was no growth in 17.7% of samples, and 8.3% of samples were contaminated. Clinical mastitis is a common disease in dairy cows in Ontario; approximately 1 in 5 cow lactations have at lease one episode of clinical mastitis. There is, however, considerable variation in the incidence of clinical mastitis among farms. The majority of 1st cases of clinical mastitis occur early in lactation, and the risk of clinical mastitis increases with increasing parity. Environmental, contagious, and minor pathogens were all associated with cases of clinical mastitis.     

Quarter,cow, and farm risk factors for intramammary infections with major pathogens relative to minor pathogens in Thai dairy cows

A cross-sectional study was carried out from May to September 2011 on 35 smallholder dairy farms in Chiang Mai, Thailand, to identify the quarter, cow, and farm factors that relate to intramammary infections (IMI) from major specified pathogens, compared to infections from minor pathogens. Data on general farm management, milking management, and dry cow management were recorded for each herd. Quarter milk samples were collected from either clinical or subclinical mastitis quarters. Dependent variables were binary data defining the specified major pathogens, including Streptococcus agalactiae (7.1 %), Streptococcus uberis (9.4 %), Streptococcus dysgalactiae (4.0 %), and other streptococci (16.7 %), as a case, and all minor pathogens as a control, in each dependent variable. The occurrence of S. agalactiae IMI was lower in first-parity cows and cows with short milking time. Cows with body condition score (BCS) <2.5 had higher occurrence of S. agalactiae IMI. The occurrence of S. uberis IMI was higher in quarters with California mastitis test (CMT) score 2, score 3, and having clinical mastitis and in farms with increasing age of vacuum system. Quarters with CMT score 3, having clinical mastitis, cow with manual milking after detaching milking cluster, and farms with high bulk milk somatic cell counts (BMSCC >500,000 cells/ml) had higher occurrence of S. dysgalactiae IMI. For other streptococci, quarters having clinical mastitis, BCS <2.5, and pulling down of milking cluster while milking increased occurrence of other streptococci IMI relative to minor pathogen IMI. These results highlight the importance of individual cow factors, milking characteristics, and BMSCC in determining the risk of IMI from major pathogens.     

Prevalence of clinical mastitis in 38 Waikato dairy herds in early lactation

AIM: To determine the prevalence of clinical mastitis in spring-calving dairy herds in the Waikato Region of New Zealand and to identify factors associated with variation in the prevalence of clinical mastitis between herds. METHOD: A total of 799 quarters from 595 dairy cows from 38 dairy herds were diagnosed by herd owners as having clinical mastitis between 8 July and 21 August 1997. Quarters diagnosed with clinical mastitis were sampled for bacterial culture and somatic cell count, and the presence of clots in the milk and the presence of udder oedema were assessed by a technician or veterinarian. RESULTS: Clinical mastitis was diagnosed in an average (+/-s.e.m.) of 9.9% (+/-0.8%, range 0.9-21.4%) of calved cows within the herds. Bacteria were not cultured from an average of 12.4 % (+/- 2.0%, range 0.0-45.5%) of cows and 22.3% (+/- 2.4%, range 0.0-54.0%) of quarters diagnosed as having clinical mastitis. There were significant differences between herds in the proportion of cows diagnosed with mastitis and in the proportion of clinical mastitis cases from which bacteria were not cultured. A decreased prevalence of clinical mastitis (p<0.001) was associated with an increased percentage of the herd treated with dry cow antibiotics. An increased prevalence of clinical mastitis (p<0.0001) was associated with both an increased percentage of cows treated in the previous season with lactating cow antibiotics and an increased percentage of heifers in the herd. Herds that were fed supplements before or during lactation had a higher prevalence of clinical mastitis than herds that were not fed supplements (p<0.001). An increased proportion of quarters diagnosed with clinical mastitis that did not culture bacteria was associated with an increased prevalence of clinical mastitis (p<0.001). The proportion of quarters that the technician or veterinarian found with evidence of clinical mastitis (i.e. a somatic cell count >500,000 cells/ml and the presence of either clots or udder oedema) within a herd was inversely related to the proportion of quarters within a herd from which no bacteria were isolated. CONCLUSION: There was a large variation in the prevalence of clinical mastitis and in the proportion of clinical quarters from which no bacteria were grown between herds. Management factors such as the use of dry cow therapy, feeding regimes and heifer replacement rates all affected the prevalence of clinical mastitis. Herd owners appear to differ in the sensitivity and specificity of their diagnosis of clinical mastitis, with bacteria not isolated from up to 50% of quarters diagnosed with clinical mastitis in some herds. Improvements in the specificity of herd owner diagnosis of clinical mastitis may reduce the use of antibiotics for mastitis during lactation and hence may reduce the risk of antibiotic contamination of milk supplied for human consumption.